Advances in Cancer Research, Volume 137, the latest release in this ongoing, well-regarded serial provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents original reviews on research bridging oncology and gene expression, with this volume covering unconventional approaches to modulating the immunogenicity of tumor cells, tumor dormancy and immunoediting, the emerging role of anti-apoptotic Bcl-2 family proteins in chemoresistance, Beclin-1 and autophagy, MDA-7/IL-24, and nanotechnology and medicine.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. vii 6. Chapter One: Unconventional Approaches to Modulating the Immunogenicity of Tumor Cells - p. vii 7. Chapter Two: A Theoretical Basis for the Efficacy of Cancer Immunotherapy and Immunogenic Tumor Dormancy: The Adaptation Model of Immunity - p. 15 8. Chapter Three: Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer - p. 36 9. Chapter Four: New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor Activity - p. 75 10. Chapter Five: Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery - p. 114 11. Chapter Six: Evaluation of Resveratrol in Cancer Patients and Experimental Models - p. 170
Advances in Cancer Research, Volume 137, the latest release in this ongoing, well-regarded serial provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents original reviews on research bridging oncology and gene expression, with this volume covering unconventional approaches to modulating the immunogenicity of tumor cells, tumor dormancy and immunoediting, the emerging role of anti-apoptotic Bcl-2 family proteins in chemoresistance, Beclin-1 and autophagy, MDA-7/IL-24, and nanotechnology and medicine.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. vii 6. Chapter One: Unconventional Approaches to Modulating the Immunogenicity of Tumor Cells - p. vii 7. Chapter Two: A Theoretical Basis for the Efficacy of Cancer Immunotherapy and Immunogenic Tumor Dormancy: The Adaptation Model of Immunity - p. 15 8. Chapter Three: Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer - p. 36 9. Chapter Four: New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor Activity - p. 75 10. Chapter Five: Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery - p. 114 11. Chapter Six: Evaluation of Resveratrol in Cancer Patients and Experimental Models - p. 170
